Wednesday, 9 August 2017

Ajanta Pharma Cons (YoY)


Profit At Rs 95 Cr Vs Rs 120 Cr;

 Revenue Down 0.6% At Rs 473 Cr;

 EBITDA Down 23% At Rs 127.4 Cr
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)